MedPath
FDA Approval

Prenate Essential

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 22, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Icosapent(40 mg in 1 1)
Vitamin C(90 mg in 1 1)
Vitamin D3(220 [iU] in 1 1)
Pyridoxine(26 mg in 1 1)
Folic acid(400 ug in 1 1)
Vitamin B12(13 ug in 1 1)
Biotin(280 ug in 1 1)
Calcium(155 mg in 1 1)
Potassium Iodide(150 ug in 1 1)
Magnesium oxide(50 mg in 1 1)
Doconexent(300 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Avion Pharmaceuticals, LLC

Avion Pharmaceuticals, LLC

040348516

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Prenate Essential

Product Details

NDC Product Code
75854-313
Route of Administration
ORAL
Effective Date
January 7, 2021
IcosapentActive
Code: AAN7QOV9EAClass: ACTIBQuantity: 40 mg in 1 1
GELATINInactive
Code: 2G86QN327LClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62Class: IACT
WHITE WAXInactive
Code: 7G1J5DA97FClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SOYBEAN OILInactive
Code: 241ATL177AClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FD&C YELLOW NO. 5Inactive
Code: I753WB2F1MClass: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
Vitamin CActive
Code: PQ6CK8PD0RClass: ACTIBQuantity: 90 mg in 1 1
Code: 1C6V77QF41Class: ACTIBQuantity: 220 [iU] in 1 1
Code: 68Y4CF58BVClass: ACTIMQuantity: 26 mg in 1 1
Code: 935E97BOY8Class: ACTIBQuantity: 400 ug in 1 1
Code: TYK22LML8FClass: ACTIMQuantity: 600 ug in 1 1
Code: P6YC3EG204Class: ACTIBQuantity: 13 ug in 1 1
BiotinActive
Code: 6SO6U10H04Class: ACTIBQuantity: 280 ug in 1 1
CalciumActive
Code: NP3JD65NPYClass: ACTIMQuantity: 155 mg in 1 1
Code: H7426RGB3LClass: ACTIMQuantity: 18 mg in 1 1
Code: 1C4QK22F9JClass: ACTIMQuantity: 150 ug in 1 1
Code: 3A3U0GI71GClass: ACTIMQuantity: 50 mg in 1 1
Code: ZAD9OKH9JCClass: ACTIBQuantity: 300 mg in 1 1
Code: WR1WPI7EW8Class: ACTIMQuantity: 10 [iU] in 1 1

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

75854-313-30

PRENATE ESSENTIAL**®******


** Rx prenatal vitamin & DHA**

• Key vitamins, minerals, and DHA support nutrition

GLUTEN FREE


** Rx Only**


** Dietary Supplement**

30 Softgels

Essencial


RECENT MAJOR CHANGES SECTION


DESCRIPTION SECTION

DESCRIPTION: PRENATE ESSENTIAL ® is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. Each softgel is green in color, opaque, and imprinted with "Prenate" on one side and blank on the other.

Prenate Essencial

PRENATE ESSENTIAL ® contains fish oil and soy.

**OTHER INGREDIENTS:**Capsule gelatin (gelatin, sorbitol, glycerin, purified water, turmeric, and sodium copper chlorophyllin), soy lecithin, yellow beeswax and soybean oil.


INDICATIONS & USAGE SECTION

INDICATIONS: PRENATE ESSENTIAL ® is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.

PRENATE ESSENTIAL ® can also be beneficial in improving the nutritional status of women prior to conception

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION: Before, during and/or after pregnancy, one softgel daily or as directed by a physician.


CONTRAINDICATIONS SECTION

CONTRAINDICATIONS: PRENATE ESSENTIAL ® is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNINGS SECTION

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

BOXED WARNING SECTION

PRECAUTIONS SECTION

PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.


ADVERSE REACTIONS SECTION

ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.


HOW SUPPLIED SECTION

HOW SUPPLIED: Bottles of 30 softgels (75854-313-30).

The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.

STORAGE AND HANDLING SECTION

STORAGE: Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.]


SPL UNCLASSIFIED SECTION

MANUFACTURED FOR: Avion Pharmaceuticals, LLC

Atlanta, GA 30005

1-888-61-AVION

Rev. 0519-01

Formical ® is a registered trademark of Nephro-Tech 1, LLC, covered by one or more claims of U.S. Patent No. 6,528,542.

Sumalate ® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 5,516,925, 6,716,814, 8,007,846, and 8,425,956.


© Copyright 2025. All Rights Reserved by MedPath